JPRN-UMIN000014092
Completed
未知
Study of association between effect of first EGFR-TKI for EGFR-mutated non-small cell lung cancer and circulating tumor DNA detected with high sensitive analyses for EGFR mutation. - Analysis of ctDNA and first EGFR-TKI
Miyagi CancerCenter0 sites30 target enrollmentMay 28, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Miyagi CancerCenter
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Received EGFR\-TKI before this study 2\.Interstitial pneumonitis or pulmonary fibrosis apparent on chest X\-ray 3\.Concomitant other malignancies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Phase 1
A Phase 1/2 study to determine the effect of Doxorubicin loaded EnGeneIC Delivery Vehicles on progression free survival in Patients with Recurrent Glioblastoma Multiforme (GBM)Recurrent Glioblastoma MultiformeCancer - BrainACTRN12613000297729EnGeneIC Ltd46
Completed
Not Applicable
The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter studyEGFR mutations in lung non-adeno and non small cell carcinomaJPRN-UMIN000007294ung Oncology Group in Kyushu, Japan (LOGIK)100
Not yet recruiting
Not Applicable
Study of Cushings diseaseCTRI/2020/07/026882All India Institute of Medical Sciences
Unknown
Phase 2
Panitumumab Skin Toxicity Prevention TrialColorectal Cancer MetastaticSkin ToxicityNCT03167268Ospedale San Carlo Borromeo28
Completed
Not Applicable
Prospective observational study of EGFR mutation allele frequency using Cell free DNAJPRN-UMIN000036149Hamamatsu University School of Medicine33